3D printing is driving a shift in patient care away from a generalised model and towards personalised treatments. To complement fast-paced clinical environments, 3D printing technologies must provide sufficiently high throughputs for them to be feasibly implemented. Volumetric printing is an emerging 3D printing technology that affords such speeds, being capable of producing entire objects within seconds. In this study, for the first time, rotatory volumetric printing was used to simultaneously produce two torus-or cylinder-shaped paracetamol -loaded Printlets (3D printed tablets). Six resin formulations comprising paracetamol as the model drug, poly (ethylene glycol) diacrylate (PEGDA) 575 or 700 as photoreactive monomers, water and PEG 30...
Embedded three-dimensional printing (e-3DP) is an emerging method for additive manufacturing where s...
The recent introduction of the first FDA approved 3D-printed drug has fuelled interest in 3D printin...
Abstract of poster presented at the 12th PBP World Meeting on Pharmaceutics, Biopharmaceutics and Ph...
3D printing is driving a shift in patient care away from a generalised model and towards personalise...
3D printing (3DP), or additive manufacturing, has been actively investigated as one of the enabling ...
An extrusion based 3D printer was used to fabricate paracetamol tablets with different geometries (m...
The manufacture of immediate release high drug loading paracetamol oral tablets was achieved using a...
Most pharmaceutical manufacturing techniques are well suited for mass manufacturing but are wholly u...
Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by po...
The development of personalized medicine requires new approaches to the development of dosage forms ...
Three-dimensional (3D) printing enables the production of different objects adjusted for the specifi...
- 3D Printing drug is to design and develop medicine that are suited to an individual. Pharmaceutica...
Three dimensional printing (3D printing) was used to fabricate novel oral drug delivery devices with...
In respect of personalised doses, fused deposition modelling 3D printing delivers a viable alternati...
Three dimensional (3D) printing has emerged as one of the most promising additive manufacturing tech...
Embedded three-dimensional printing (e-3DP) is an emerging method for additive manufacturing where s...
The recent introduction of the first FDA approved 3D-printed drug has fuelled interest in 3D printin...
Abstract of poster presented at the 12th PBP World Meeting on Pharmaceutics, Biopharmaceutics and Ph...
3D printing is driving a shift in patient care away from a generalised model and towards personalise...
3D printing (3DP), or additive manufacturing, has been actively investigated as one of the enabling ...
An extrusion based 3D printer was used to fabricate paracetamol tablets with different geometries (m...
The manufacture of immediate release high drug loading paracetamol oral tablets was achieved using a...
Most pharmaceutical manufacturing techniques are well suited for mass manufacturing but are wholly u...
Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by po...
The development of personalized medicine requires new approaches to the development of dosage forms ...
Three-dimensional (3D) printing enables the production of different objects adjusted for the specifi...
- 3D Printing drug is to design and develop medicine that are suited to an individual. Pharmaceutica...
Three dimensional printing (3D printing) was used to fabricate novel oral drug delivery devices with...
In respect of personalised doses, fused deposition modelling 3D printing delivers a viable alternati...
Three dimensional (3D) printing has emerged as one of the most promising additive manufacturing tech...
Embedded three-dimensional printing (e-3DP) is an emerging method for additive manufacturing where s...
The recent introduction of the first FDA approved 3D-printed drug has fuelled interest in 3D printin...
Abstract of poster presented at the 12th PBP World Meeting on Pharmaceutics, Biopharmaceutics and Ph...